Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aditxt Inc (NQ: ADTX )

1.350 -0.030 (-2.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 185,532
Open 1.430
Bid (Size) 1.350 (1)
Ask (Size) 1.390 (1)
Prev. Close 1.380
Today's Range 1.310 - 1.440
52wk Range 1.300 - 68.08
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX), Appili Therapeutics Sign Second Amendent to Acquisition Agreement
Via Investor Brand Network
Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st
Live moderated video webcast with Evofem management on Thursday, August 1 at 10:30am ET 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
-71.88%
-71.88%
1 Month
-2.88%
-2.88%
3 Month
-43.51%
-43.51%
6 Month
-65.47%
-65.47%
1 Year
-91.35%
-91.35%

More News

Read More
Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition
From Aditxt, Inc.
Via Business Wire
What's Going On With Aditxt Shares Wednesday?
Via Benzinga
BioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Inks Middle East License, Supply Agreement for Proprietary Birth Control Product
Via Investor Brand Network
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
ADTX Stock Earnings: Aditxt Reported Results for Q1 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Dow Jumps 200 Points; Synchrony Financial Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Rises 2%; Five Below Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX), Evofem Biosciences (EVFM) Announce Amended, Restates Merger Agreement
Via Investor Brand Network
Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estimates
Via Benzinga
Why Is New Horizon Aircraft (HOVR) Stock Down 6% Today?
Via InvestorPlace
Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing
From Aditxt, Inc.
Via Business Wire
BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX), Evofem Biosciences (EVFM) Announce Market Partnership with Hello Alpha
Via Investor Brand Network
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Merger Target Expects ‘Fourth Consecutive Year of Net Sales Growth’
Via Investor Brand Network
CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules
From Aditxt, Inc.
Via Business Wire
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Securities Purchase Agreements, Anticipates Receiving Approximately $4.2M from Placement
Via Investor Brand Network
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Aditxt Stock Is Volatile Today
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
From Aditxt, Inc.
Via Business Wire
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Acquisition Target Reports Increased Product Sales, Ongoing Revenue Growth
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.